Stephens Inc’s Alignment Healthcare ALHC Stock Holding History

Stephens Inc’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,876	Closed	-$389K	–	1277
2025 Q1	$389K	Buy	+20,876	New	+$311K	0.01%	902

Other funds holding ALHC

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

8KM

8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stephens Inc's ALHC Position: Q2 2025 in Review

Stephens Inc sold out of Alignment Healthcare (ALHC) in Q2 2025, closing a stake of 20,876 shares — an estimated $389K sold.

Stephens Inc first reported a position in ALHC in Q1 2025 and held it in 1 quarter. The position peaked at $389K in Q1 2025. 217 funds tracked by Wall St. Rank hold ALHC as of Q2 2025.

Stephens Inc reported no remaining Alignment Healthcare position as of Q2 2025 after selling out during the quarter.
Stephens Inc sold 20,876 Alignment Healthcare shares in Q2 2025, an estimated $389K.
Stephens Inc first reported a position in Alignment Healthcare in Q1 2025 and held it in 1 quarter.
Stephens Inc's Alignment Healthcare position peaked at $389K in Q1 2025.
217 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2025.

Based on Stephens Inc's 13F filing for Q2 2025, filed 29 Jul 2025.